[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
Identifieur interne : 000022 ( PubMed/Checkpoint ); précédent : 000021; suivant : 000023[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
Auteurs : C. Liu [République populaire de Chine] ; Z C Jiang [République populaire de Chine] ; C X Shao [République populaire de Chine] ; H G Zhang [République populaire de Chine] ; H M Yue [République populaire de Chine] ; Z H Chen [République populaire de Chine] ; B Y Ma [République populaire de Chine] ; W Y Liu [République populaire de Chine] ; H H Huang [République populaire de Chine] ; J. Yang [République populaire de Chine] ; Y. Wang [République populaire de Chine] ; H Y Liu [République populaire de Chine] ; D. Xu [République populaire de Chine] ; J T Wang [République populaire de Chine] ; J Y Yang [République populaire de Chine] ; H Q Pan [République populaire de Chine] ; S Q Zou [République populaire de Chine] ; F J Li [République populaire de Chine] ; J Q Lei [République populaire de Chine] ; X. Li [République populaire de Chine] ; Q. He [République populaire de Chine] ; Y. Gu [République populaire de Chine] ; X L Qi [République populaire de Chine]Source :
- Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [ 1007-3418 ] ; 2020.
Abstract
Objective: To analyze the clinical characteristics of cases of novel coronavirus pneumonia and a preliminary study to explore the relationship between different clinical classification and liver damage. Methods: Consecutively confirmed novel coronavirus infection cases admitted to seven designated hospitals during January 23, 2020 to February 8, 2020 were included. Clinical classification (mild, moderate, severe, and critical) was carried out according to the diagnosis and treatment program of novel coronavirus pneumonia (Trial Fifth Edition) issued by the National Health Commission. The research data were analyzed using SPSS19.0 statistical software. Quantitative data were expressed as median (interquartile range), and qualitative data were expressed as frequency and rate. Results: 32 confirmed cases that met the inclusion criteria were included. 28 cases were of mild or moderate type (87.50%), and four cases (12.50%) of severe or critical type. Four cases (12.5%) were combined with one underlying disease (bronchial asthma, coronary heart disease, malignant tumor, chronic kidney disease), and one case (3.13%) was simultaneously combined with high blood pressure and malignant tumor. The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34- ~ 21.15) mmol/L, respectively. ALT, AST, ALB and TBil of the mild or moderate subgroups were 22.75 (16.31- ~ 37.25) U/L, 23.63 (18.71 ~ 26.50) U/L, 39.70 (36.50 ~ 46.10) g/L, and 15.95 (11.34 ~ 20.83) mmol/L, respectively. ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) mmol/L, respectively. Conclusion: The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients.
DOI: 10.3760/cma.j.issn.1007-3418.2020.02.003
PubMed: 32077660
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32077660Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].</title><author><name sortKey="Liu, C" sort="Liu, C" uniqKey="Liu C" first="C" last="Liu">C. Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Jiang, Z C" sort="Jiang, Z C" uniqKey="Jiang Z" first="Z C" last="Jiang">Z C Jiang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Ankang Central Hospital, Ankang 725000</wicri:regionArea><wicri:noRegion>Ankang 725000</wicri:noRegion></affiliation></author><author><name sortKey="Shao, C X" sort="Shao, C X" uniqKey="Shao C" first="C X" last="Shao">C X Shao</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Lishui Central Hospital, Lishui 323000</wicri:regionArea><wicri:noRegion>Lishui 323000</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, H G" sort="Zhang, H G" uniqKey="Zhang H" first="H G" last="Zhang">H G Zhang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Yue, H M" sort="Yue, H M" uniqKey="Yue H" first="H M" last="Yue">H M Yue</name><affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Chen, Z H" sort="Chen, Z H" uniqKey="Chen Z" first="Z H" last="Chen">Z H Chen</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000</wicri:regionArea><wicri:noRegion>Baoding 071000</wicri:noRegion></affiliation></author><author><name sortKey="Ma, B Y" sort="Ma, B Y" uniqKey="Ma B" first="B Y" last="Ma">B Y Ma</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of LinXia Hui Prefecture, Linxia 731100, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of LinXia Hui Prefecture, Linxia 731100</wicri:regionArea><wicri:noRegion>Linxia 731100</wicri:noRegion></affiliation></author><author><name sortKey="Liu, W Y" sort="Liu, W Y" uniqKey="Liu W" first="W Y" last="Liu">W Y Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Huang, H H" sort="Huang, H H" uniqKey="Huang H" first="H H" last="Huang">H H Huang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Ankang Central Hospital, Ankang 725000</wicri:regionArea><wicri:noRegion>Ankang 725000</wicri:noRegion></affiliation></author><author><name sortKey="Yang, J" sort="Yang, J" uniqKey="Yang J" first="J" last="Yang">J. Yang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Lishui Central Hospital, Lishui 323000</wicri:regionArea><wicri:noRegion>Lishui 323000</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Y" sort="Wang, Y" uniqKey="Wang Y" first="Y" last="Wang">Y. Wang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Liu, H Y" sort="Liu, H Y" uniqKey="Liu H" first="H Y" last="Liu">H Y Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Xu, D" sort="Xu, D" uniqKey="Xu D" first="D" last="Xu">D. Xu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Wang, J T" sort="Wang, J T" uniqKey="Wang J" first="J T" last="Wang">J T Wang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Yang, J Y" sort="Yang, J Y" uniqKey="Yang J" first="J Y" last="Yang">J Y Yang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Pan, H Q" sort="Pan, H Q" uniqKey="Pan H" first="H Q" last="Pan">H Q Pan</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Zou, S Q" sort="Zou, S Q" uniqKey="Zou S" first="S Q" last="Zou">S Q Zou</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Li, F J" sort="Li, F J" uniqKey="Li F" first="F J" last="Li">F J Li</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000</wicri:regionArea><wicri:noRegion>Baoding 071000</wicri:noRegion></affiliation></author><author><name sortKey="Lei, J Q" sort="Lei, J Q" uniqKey="Lei J" first="J Q" last="Lei">J Q Lei</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Li, X" sort="Li, X" uniqKey="Li X" first="X" last="Li">X. Li</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="He, Q" sort="He, Q" uniqKey="He Q" first="Q" last="He">Q. He</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Third People's Hospital of Shenzhen, Shenzhen 518100, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Third People's Hospital of Shenzhen, Shenzhen 518100</wicri:regionArea><placeName><settlement type="city">Shenzhen</settlement><region type="province">Guangdong</region></placeName></affiliation></author><author><name sortKey="Gu, Y" sort="Gu, Y" uniqKey="Gu Y" first="Y" last="Gu">Y. Gu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Qi, X L" sort="Qi, X L" uniqKey="Qi X" first="X L" last="Qi">X L Qi</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32077660</idno><idno type="pmid">32077660</idno><idno type="doi">10.3760/cma.j.issn.1007-3418.2020.02.003</idno><idno type="wicri:Area/PubMed/Corpus">000532</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000532</idno><idno type="wicri:Area/PubMed/Curation">000532</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000532</idno><idno type="wicri:Area/PubMed/Checkpoint">000022</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000022</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].</title><author><name sortKey="Liu, C" sort="Liu, C" uniqKey="Liu C" first="C" last="Liu">C. Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Jiang, Z C" sort="Jiang, Z C" uniqKey="Jiang Z" first="Z C" last="Jiang">Z C Jiang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Ankang Central Hospital, Ankang 725000</wicri:regionArea><wicri:noRegion>Ankang 725000</wicri:noRegion></affiliation></author><author><name sortKey="Shao, C X" sort="Shao, C X" uniqKey="Shao C" first="C X" last="Shao">C X Shao</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Lishui Central Hospital, Lishui 323000</wicri:regionArea><wicri:noRegion>Lishui 323000</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, H G" sort="Zhang, H G" uniqKey="Zhang H" first="H G" last="Zhang">H G Zhang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Yue, H M" sort="Yue, H M" uniqKey="Yue H" first="H M" last="Yue">H M Yue</name><affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Chen, Z H" sort="Chen, Z H" uniqKey="Chen Z" first="Z H" last="Chen">Z H Chen</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000</wicri:regionArea><wicri:noRegion>Baoding 071000</wicri:noRegion></affiliation></author><author><name sortKey="Ma, B Y" sort="Ma, B Y" uniqKey="Ma B" first="B Y" last="Ma">B Y Ma</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of LinXia Hui Prefecture, Linxia 731100, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of LinXia Hui Prefecture, Linxia 731100</wicri:regionArea><wicri:noRegion>Linxia 731100</wicri:noRegion></affiliation></author><author><name sortKey="Liu, W Y" sort="Liu, W Y" uniqKey="Liu W" first="W Y" last="Liu">W Y Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Huang, H H" sort="Huang, H H" uniqKey="Huang H" first="H H" last="Huang">H H Huang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Ankang Central Hospital, Ankang 725000</wicri:regionArea><wicri:noRegion>Ankang 725000</wicri:noRegion></affiliation></author><author><name sortKey="Yang, J" sort="Yang, J" uniqKey="Yang J" first="J" last="Yang">J. Yang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, Lishui Central Hospital, Lishui 323000</wicri:regionArea><wicri:noRegion>Lishui 323000</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Y" sort="Wang, Y" uniqKey="Wang Y" first="Y" last="Wang">Y. Wang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Liu, H Y" sort="Liu, H Y" uniqKey="Liu H" first="H Y" last="Liu">H Y Liu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Xu, D" sort="Xu, D" uniqKey="Xu D" first="D" last="Xu">D. Xu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Wang, J T" sort="Wang, J T" uniqKey="Wang J" first="J T" last="Wang">J T Wang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Yang, J Y" sort="Yang, J Y" uniqKey="Yang J" first="J Y" last="Yang">J Y Yang</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Pan, H Q" sort="Pan, H Q" uniqKey="Pan H" first="H Q" last="Pan">H Q Pan</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Zou, S Q" sort="Zou, S Q" uniqKey="Zou S" first="S Q" last="Zou">S Q Zou</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021</wicri:regionArea><wicri:noRegion>Zhenjiang 212021</wicri:noRegion></affiliation></author><author><name sortKey="Li, F J" sort="Li, F J" uniqKey="Li F" first="F J" last="Li">F J Li</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000</wicri:regionArea><wicri:noRegion>Baoding 071000</wicri:noRegion></affiliation></author><author><name sortKey="Lei, J Q" sort="Lei, J Q" uniqKey="Lei J" first="J Q" last="Lei">J Q Lei</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="Li, X" sort="Li, X" uniqKey="Li X" first="X" last="Li">X. Li</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author><author><name sortKey="He, Q" sort="He, Q" uniqKey="He Q" first="Q" last="He">Q. He</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Third People's Hospital of Shenzhen, Shenzhen 518100, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Third People's Hospital of Shenzhen, Shenzhen 518100</wicri:regionArea><placeName><settlement type="city">Shenzhen</settlement><region type="province">Guangdong</region></placeName></affiliation></author><author><name sortKey="Gu, Y" sort="Gu, Y" uniqKey="Gu Y" first="Y" last="Gu">Y. Gu</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006</wicri:regionArea><wicri:noRegion>Shenyang 110006</wicri:noRegion></affiliation></author><author><name sortKey="Qi, X L" sort="Qi, X L" uniqKey="Qi X" first="X L" last="Qi">X L Qi</name><affiliation wicri:level="1"><nlm:affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000</wicri:regionArea><wicri:noRegion>Lanzhou 730000</wicri:noRegion></affiliation></author></analytic><series><title level="j">Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology</title><idno type="ISSN">1007-3418</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><b>Objective:</b> To analyze the clinical characteristics of cases of novel coronavirus pneumonia and a preliminary study to explore the relationship between different clinical classification and liver damage. <b>Methods:</b> Consecutively confirmed novel coronavirus infection cases admitted to seven designated hospitals during January 23, 2020 to February 8, 2020 were included. Clinical classification (mild, moderate, severe, and critical) was carried out according to the diagnosis and treatment program of novel coronavirus pneumonia (Trial Fifth Edition) issued by the National Health Commission. The research data were analyzed using SPSS19.0 statistical software. Quantitative data were expressed as median (interquartile range), and qualitative data were expressed as frequency and rate. <b>Results:</b> 32 confirmed cases that met the inclusion criteria were included. 28 cases were of mild or moderate type (87.50%), and four cases (12.50%) of severe or critical type. Four cases (12.5%) were combined with one underlying disease (bronchial asthma, coronary heart disease, malignant tumor, chronic kidney disease), and one case (3.13%) was simultaneously combined with high blood pressure and malignant tumor. The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34- ~ 21.15) mmol/L, respectively. ALT, AST, ALB and TBil of the mild or moderate subgroups were 22.75 (16.31- ~ 37.25) U/L, 23.63 (18.71 ~ 26.50) U/L, 39.70 (36.50 ~ 46.10) g/L, and 15.95 (11.34 ~ 20.83) mmol/L, respectively. ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) mmol/L, respectively. <b>Conclusion:</b> The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32077660</PMID><DateRevised><Year>2020</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1007-3418</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology</Title><ISOAbbreviation>Zhonghua Gan Zang Bing Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].</ArticleTitle><Pagination><MedlinePgn>148-152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.1007-3418.2020.02.003</ELocationID><Abstract><AbstractText><b>Objective:</b> To analyze the clinical characteristics of cases of novel coronavirus pneumonia and a preliminary study to explore the relationship between different clinical classification and liver damage. <b>Methods:</b> Consecutively confirmed novel coronavirus infection cases admitted to seven designated hospitals during January 23, 2020 to February 8, 2020 were included. Clinical classification (mild, moderate, severe, and critical) was carried out according to the diagnosis and treatment program of novel coronavirus pneumonia (Trial Fifth Edition) issued by the National Health Commission. The research data were analyzed using SPSS19.0 statistical software. Quantitative data were expressed as median (interquartile range), and qualitative data were expressed as frequency and rate. <b>Results:</b> 32 confirmed cases that met the inclusion criteria were included. 28 cases were of mild or moderate type (87.50%), and four cases (12.50%) of severe or critical type. Four cases (12.5%) were combined with one underlying disease (bronchial asthma, coronary heart disease, malignant tumor, chronic kidney disease), and one case (3.13%) was simultaneously combined with high blood pressure and malignant tumor. The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34- ~ 21.15) mmol/L, respectively. ALT, AST, ALB and TBil of the mild or moderate subgroups were 22.75 (16.31- ~ 37.25) U/L, 23.63 (18.71 ~ 26.50) U/L, 39.70 (36.50 ~ 46.10) g/L, and 15.95 (11.34 ~ 20.83) mmol/L, respectively. ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) mmol/L, respectively. <b>Conclusion:</b> The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Z C</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>C X</ForeName><Initials>CX</Initials><AffiliationInfo><Affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>H G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Z H</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>B Y</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The People's Hospital of LinXia Hui Prefecture, Linxia 731100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>W Y</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>H H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>COVID-19 study group, Ankang Central Hospital, Ankang 725000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>COVID-19 study group, Lishui Central Hospital, Lishui 323000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>H Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>J T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>J Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>H Q</ForeName><Initials>HQ</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>S Q</ForeName><Initials>SQ</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Affiliated Third Hospital of Jiangsu University, Zhenjiang 212021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The People's Hospital of Baoding, Baoding 071000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>J Q</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Third People's Hospital of Shenzhen, Shenzhen 518100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The Sixth People's Hospital of Shenyang, Shenyang 110006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>X L</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>COVID-19 study group, The First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>YJ2020-9-009</GrantID><Agency>Shenyang Emergency Research Project for Prevention and Treatment of COVID-19</Agency><Country></Country></Grant><Grant><GrantID>2020-YJ005</GrantID><Agency>Shanxi Provincial Emergency Research Project for Chinese Medicine for Prevention and Treatment of COVID-19</Agency><Country></Country></Grant><Grant><GrantID>SH2020001</GrantID><Agency>Zhenjiang Key Research and Development Plan for Novel Coronavirus Pneumonia Emergency Project</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Gan Zang Bing Za Zhi</MedlineTA><NlmUniqueID>9710009</NlmUniqueID><ISSNLinking>1007-3418</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>目的：</b> 分析新型冠状病毒肺炎病例的临床特征，初步探讨不同临床分型与肝功能损伤的关系。 <b>方法：</b> 纳入2020年1月23日到2020年2月8日7家新型冠状病毒感染定点医院连续收治的确诊病例。根据国家卫生健康委员会发布的《新型冠状病毒感染的肺炎诊疗方案（试行第五版 修正版）》进行临床分型（轻型、普通型、重型、危重型）。研究数据采用SPSS19.0统计学软件进行分析。定量资料采用中位数（四分位数间距）表示，定性资料采用频数和率表示。两组数据之间的差异性分析采用秩和检验。 <b>结果：</b> 纳入了符合标准的32例确诊病例，轻型或普通型28例（87.50%），重型或危重型4例（12.50%）。4例（12.50%）患者合并有1项基础疾病（支气管哮喘、冠心病、恶性肿瘤、慢性肝脏疾病各1例），1例（3.13%）患者同时合并有高血压和恶性肿瘤。实验室检查结果提示：总队列病例的谷氨酸转氨酶（ALT）和天冬氨酸转氨酶（AST）分别为26.98（16.88～46.09）U/L和24.75（18.71～31.79）U/L，白蛋白（Alb）和总胆红素（TBil）分别为39.00 (36.20～44.20) g/L和16.40 (11.34～21.15) mmol/L。轻型或普通型亚组的ALT和AST分别为22.75 (16.31～37.25) U/L和23.63 (18.71～26.50）U/L，其中ALT > 40 U/L有6例（21.00%），AST > 40 U/L有1例（3.60%）；Alb和TBil分别为39.70 (36.50～46.10) g/L和15.95 (11.34～20.83) mmol/L。重型或危重型亚组的ALT和AST分别为60.25 (40.88～68.90) U/L和37.00 (20.88～64.45) U/L，其中ALT > 40 U/L有3例（75.00%），AST > 40 U/L有1例（25.00%）；Alb和TBil分别为35.75 (28.68～42.00) g/L和20.50 (11.28～25.00) mmol/L。 <b>结论：</b> 多中心回顾性研究结果提示新型冠状病毒肺炎合并肝功能损伤在轻型和普通型患者中少见，而在重型和危重型患者中多见。因此，应当加强对重症患者治疗期间的肝功能监测与评估。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical typing</Keyword><Keyword MajorTopicYN="N">Hypohepatia</Keyword><Keyword MajorTopicYN="N">Liver function</Keyword><Keyword MajorTopicYN="N">NCP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32077660</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.1007-3418.2020.02.003</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><region><li>Guangdong</li></region><settlement><li>Shenzhen</li></settlement></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Liu, C" sort="Liu, C" uniqKey="Liu C" first="C" last="Liu">C. Liu</name></noRegion><name sortKey="Chen, Z H" sort="Chen, Z H" uniqKey="Chen Z" first="Z H" last="Chen">Z H Chen</name><name sortKey="Gu, Y" sort="Gu, Y" uniqKey="Gu Y" first="Y" last="Gu">Y. Gu</name><name sortKey="He, Q" sort="He, Q" uniqKey="He Q" first="Q" last="He">Q. He</name><name sortKey="Huang, H H" sort="Huang, H H" uniqKey="Huang H" first="H H" last="Huang">H H Huang</name><name sortKey="Jiang, Z C" sort="Jiang, Z C" uniqKey="Jiang Z" first="Z C" last="Jiang">Z C Jiang</name><name sortKey="Lei, J Q" sort="Lei, J Q" uniqKey="Lei J" first="J Q" last="Lei">J Q Lei</name><name sortKey="Li, F J" sort="Li, F J" uniqKey="Li F" first="F J" last="Li">F J Li</name><name sortKey="Li, X" sort="Li, X" uniqKey="Li X" first="X" last="Li">X. Li</name><name sortKey="Liu, H Y" sort="Liu, H Y" uniqKey="Liu H" first="H Y" last="Liu">H Y Liu</name><name sortKey="Liu, W Y" sort="Liu, W Y" uniqKey="Liu W" first="W Y" last="Liu">W Y Liu</name><name sortKey="Ma, B Y" sort="Ma, B Y" uniqKey="Ma B" first="B Y" last="Ma">B Y Ma</name><name sortKey="Pan, H Q" sort="Pan, H Q" uniqKey="Pan H" first="H Q" last="Pan">H Q Pan</name><name sortKey="Qi, X L" sort="Qi, X L" uniqKey="Qi X" first="X L" last="Qi">X L Qi</name><name sortKey="Shao, C X" sort="Shao, C X" uniqKey="Shao C" first="C X" last="Shao">C X Shao</name><name sortKey="Wang, J T" sort="Wang, J T" uniqKey="Wang J" first="J T" last="Wang">J T Wang</name><name sortKey="Wang, Y" sort="Wang, Y" uniqKey="Wang Y" first="Y" last="Wang">Y. Wang</name><name sortKey="Xu, D" sort="Xu, D" uniqKey="Xu D" first="D" last="Xu">D. Xu</name><name sortKey="Yang, J" sort="Yang, J" uniqKey="Yang J" first="J" last="Yang">J. Yang</name><name sortKey="Yang, J Y" sort="Yang, J Y" uniqKey="Yang J" first="J Y" last="Yang">J Y Yang</name><name sortKey="Yue, H M" sort="Yue, H M" uniqKey="Yue H" first="H M" last="Yue">H M Yue</name><name sortKey="Zhang, H G" sort="Zhang, H G" uniqKey="Zhang H" first="H G" last="Zhang">H G Zhang</name><name sortKey="Zou, S Q" sort="Zou, S Q" uniqKey="Zou S" first="S Q" last="Zou">S Q Zou</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000022 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000022 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32077660
|texte= [Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32077660" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |